Increase in sales of ProSense®, based on preliminary unaudited results, demonstrate growing adoption of ProSense® cryoablation for breast tumors. FDA decision on ...

IceCure Medical’s next-generation cryoablation technology to receive European patent: Caesarea, Israel Monday, January 6, 2025, 13:00 Hrs [IST] IceCure Medical Ltd., a developer ...

Immunotherapy is a newer class of treatment for lung and other cancers. It primes the body’s natural immune system to fight back against cancer. Immunotherapy has been shown to improve survival in ...

Icecure Medical ( ) has issued an update. IceCure Medical has received an Intention to Grant Notice from the European Patent Office for its innovative cryogenic system connector t ...

IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive ...

XSensetm system's innovative cryogenic connector technology designed to improve safety and maintain the integrity of cryogen used in the cryoablation procedure CAESAREA, Israel, Jan. 3 ...

XSense™ system's innovative cryogenic connector technology designed to improve safety and maintain the integrity of cryogen used in the cryoablation procedure "We are experiencing increased ...

Background: Cryoablation (CRYO) is an alternative to radiofrequency (RF) ablation in the treatment of atrioventricular nodal reentrant tachycardia (AVNRT). This study aims to evaluate the ...

Lung cancer is one of the most common cancers. Stage 1 lung cancer is defined by tumors that are very small and have not spread (metastasized) to other parts of the body. Despite its name, it is ...

Scientists at Newcastle University have developed a new lung scanning method that reveals the real-time effects on lung function. The technique allows the team to track how air moves in and out of the ...